Sakar Healthcare is trading 6.81% lower at ₹887.00, with no confirmed company-specific catalyst identified. - The company had scheduled a board meeting for October 23 to consider financial results; the meeting alone does not establish the cause of the decline. - The broader market backdrop described for October 22 was cautious, but available evidence does not establish a direct link to the stock’s move.